Françoise Stanke-Labesque

6PUBLICATIONS
7CO-AUTHORS
PharmacogenomicsEpidemiological modellingMolecular targetsPharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 15, 2023
Discrepancies between dihydropyrimidine dehydrogenase phenotyping and genotyping: What are the explanatory factors?

Capucine Arrivé, Xavier Fonrose, Fabienne Thomas

|Jun 02, 2021
Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data.

Léa Bolcato, Charles Khouri, Anette Veringa

|Nov 20, 2020
Optimization of voriconazole therapy for treatment of invasive aspergillosis: Pharmacogenomics and inflammatory status need to be evaluated.

Elodie Gautier-Veyret, Anne Thiebaut-Bertrand, Matthieu Roustit

|May 31, 2020
Tablets or oral suspension for posaconazole in lung transplant recipients? Consequences for trough concentrations of tacrolimus and everolimus.

Sébastien Chanoine, Elodie Gautier-Veyret, Hélène Pluchart

|Mar 22, 2020
Unexpected overdose blood concentration of tacrolimus: Keep in mind the role of inflammation.

Edouard Bonneville, Elodie Gautier-Veyret, Cordelia Ihl

|Dec 22, 2018
New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases.

Benjamin Nemoz, David Ternant, Sébastien Bailly

Pageof 1

Frequent Collaborators

3 joint publications

Elodie Gautier-Veyret

1 joint publications

Sébastien Chanoine

1 joint publications

Matthieu Roustit

1 joint publications

Charles Khouri